MIDBX | MIDLX | MIDBX / MIDLX | |
Total Expense Ratio | 2.05 | 0.91 | 225% |
Annual Report Gross Expense Ratio | 2.06 | 0.92 | 224% |
Fund Existence | 25 years | 13 years | - |
Gain YTD | 14.301 | 14.992 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.58B | 6.58B | 100% |
Annual Yield % from dividends | 1.07 | 2.17 | 49% |
Returns for 1 year | 4.09 | 5.63 | 73% |
Returns for 3 years | 16.83 | 20.94 | 80% |
Returns for 5 years | 3.40 | 10.11 | 34% |
Returns for 10 years | 14.52 | 26.89 | 54% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ICBAX | 17.38 | 0.30 | +1.76% |
ICON Natural Resources and Infras Inv | |||
GSDPX | 49.52 | 0.31 | +0.63% |
Goldman Sachs US Tax-Managed Eq P | |||
ETAHX | 34.18 | 0.21 | +0.62% |
Eventide Healthcare & Life Sciences A | |||
FCTDX | 18.31 | 0.11 | +0.60% |
Strategic Advisers Fidelity US TtlStk | |||
BLNIX | 13.12 | 0.06 | +0.46% |
Meeder Balanced Institutional |